Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Welti

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Iscience|December 24, 2025
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancerDaniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
The Journal of Clinical Investigation|April 7, 2020
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivoAbdullah Alajati, Mariantonietta D'Ambrosio, Martina Troiani, et al.
Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Cancer Research|November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate CancerVeronica Gil, Susana Miranda, Ruth Riisnaes, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
Cell|August 6, 2013
Role of PFKFB3-driven glycolysis in vessel sproutingKatrien De Bock, Maria Georgiadou, Sandra Schoors, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer GrowthJonathan Welti, Denisa Bogdan, Ines Figueiredo, et al.
Science (New York, N.Y.)|October 7, 2021
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesisNicolò Pernigoni, Elena Zagato, Arianna Calcinotto, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Iscience|December 24, 2025
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancerDaniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
The Journal of Clinical Investigation|April 7, 2020
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivoAbdullah Alajati, Mariantonietta D'Ambrosio, Martina Troiani, et al.
Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Cancer Research|November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate CancerVeronica Gil, Susana Miranda, Ruth Riisnaes, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
Cell|August 6, 2013
Role of PFKFB3-driven glycolysis in vessel sproutingKatrien De Bock, Maria Georgiadou, Sandra Schoors, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer GrowthJonathan Welti, Denisa Bogdan, Ines Figueiredo, et al.
Science (New York, N.Y.)|October 7, 2021
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesisNicolò Pernigoni, Elena Zagato, Arianna Calcinotto, et al.
Pageof 3